http://www.sciencedaily.com/releases/2015/02/150203190025.htm
FDA has recently approved life saving drugs after phase 2 clinical trials. For TBI, it is a similar situation where its the question of life and death of the patient. IMO if the trial results show that it is potentially a life saving drug , there is a reasonable chance (with the backing of US Army) that FDA may approve Trofinetide for TBI without the need of phase 3. In previous announcements, the trial (in progress) had shown lowering of the mortality rate.
A possibility worth worth contemplating
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.27 |
Change
0.920(6.41%) |
Mkt cap ! $1.951B | |||
| Open | High | Low | Value | Volume |
| $14.35 | $15.27 | $14.35 | $8.720M | 579.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $15.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.27 | 3638 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |